Have a feature idea you'd love to see implemented?
Let us know!
APTO Aptose Biosciences Inc
Price (delayed)
$0.385
Market cap
$6.97M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.36
Enterprise value
-$539,884
Aptose Biosciences is a clinical-stage biotechnology company committed to developing personalized therapies addressing unmet medical needs in oncology, with an initial focus on hematology. The Company's small molecule cancer therapeutics
Highlights
The EPS has grown by 43% year-on-year and by 30% since the previous quarter
The debt has contracted by 32% YoY and by 11% from the previous quarter
Aptose Biosciences's equity has shrunk by 116% YoY
The quick ratio has plunged by 66% YoY and by 14% from the previous quarter
Key stats
What are the main financial stats of APTO
Market
Valuations
Earnings
Shares outstanding
18.11M
Market cap
$6.97M
Enterprise value
-$539,884
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$40.29M
EBITDA
-$39.86M
Free cash flow
-$37.32M
Per share
Balance sheet
Liquidity
EPS
-$4.36
Free cash flow per share
-$2.23
Book value per share
-$0.13
Revenue per share
$0
TBVPS
$0.65
Total assets
$10.95M
Total liabilities
$13.13M
Debt
$818,000
Equity
-$2.18M
Working capital
-$2.55M
Debt to equity
-0.38
Current ratio
0.8
Quick ratio
0.66
Net debt/EBITDA
0.19
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-279.8%
Return on equity
-5,683.2%
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
APTO stock price
How has the Aptose Biosciences stock price performed over time
Intraday
-2.8%
1 week
6.94%
1 month
-3.99%
1 year
-85.02%
YTD
-84.84%
QTD
-6.3%
Financial performance
How have Aptose Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$40.91M
Net income
-$40.29M
Gross margin
N/A
Net margin
N/A
The company's operating income rose by 16% YoY and by 15% QoQ
Aptose Biosciences's net income has increased by 15% YoY and by 15% from the previous quarter
Growth
What is Aptose Biosciences's growth rate over time
Valuation
What is Aptose Biosciences stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 43% year-on-year and by 30% since the previous quarter
Aptose Biosciences's equity has shrunk by 116% YoY
Efficiency
How efficient is Aptose Biosciences business performance
The return on assets has dropped by 156% year-on-year and by 9% since the previous quarter
Dividends
What is APTO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for APTO.
Financial health
How did Aptose Biosciences financials performed over time
The total assets is 17% smaller than the total liabilities
The quick ratio has plunged by 66% YoY and by 14% from the previous quarter
The company's current ratio has shrunk by 62% YoY and by 18% QoQ
The debt is 138% more than the equity
Aptose Biosciences's equity has shrunk by 116% YoY
APTO's debt to equity has dropped by 106% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.